[1]印婷婷,约尔古丽·玉素甫阿吉,祖克拉·吐尔洪,等.冠心病血运重建患者发生不良心脑血管事件的影响因素[J].医学信息,2021,34(16):140-142.[doi:10.3969/j.issn.1006-1959.2021.16.039]
　YIN Ting-ting,Yolguli Yusufagi,Zukra Turhon,et al.Influential Factors of Adverse Cardiovascular and Cerebrovascular Events in Patients with Coronary Heart Disease Revascularization[J].Medical Information,2021,34(16):140-142.[doi:10.3969/j.issn.1006-1959.2021.16.039]
点击复制

冠心病血运重建患者发生不良心脑血管事件的影响因素()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年16期
页码:
140-142
栏目:
临床研究
出版日期:
2021-08-15

文章信息/Info

Title:
Influential Factors of Adverse Cardiovascular and Cerebrovascular Events in Patients with Coronary Heart Disease Revascularization
文章编号:
1006-1959（2021）16-0140-03
作者:
印婷婷; 约尔古丽·玉素甫阿吉; 祖克拉·吐尔洪; 等
（新疆医科大学第一附属医院心脏中心心功能科1，心脏起搏与电生理科2，新疆 乌鲁木齐 830054）
Author(s):
YIN Ting-ting; Yolguli Yusufagi; Zukra Turhon; et al.
(Heart Center,Department of Cardiac Function1,Department of Cardiac Pacing and Electrophysiology2, the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,Xinjiang,China)
关键词:
冠心病; 血运重建; 代谢综合征; 主要不良心血管事件
Keywords:
Coronary heart disease; Revascularization; Metabolic syndrome; Main adverse cardiovascular events
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2021.16.039
文献标志码:
A
摘要:
目的 探讨冠心病血运重建患者发生不良心脑血管事件的影响因素。方法 回顾性分析2012年7月~2014年7月在新疆医科大学第一附属医院接受血运重建治疗的613例冠心病患者临床资料，术后随访5年，以术后是否发生MACCE分为两组，比较两组临床因素，并采用多因素Logistic回归分析冠心病患者血运重建治疗术后发生MACCE的独立预测因素。结果 613例冠心病患者在5年的随访期间内发生MACCE 135例（22.02%），未发生MACCE 478例（77.98%）。单因素分析显示，两组年龄、空腹血糖、糖耐量异常、代谢综合征比较，差异有统计学意义（P＜0.05）；多因素Logistic回归分析显示，年龄和代谢综合征对冠心病患者血运重建治疗术后发生MACCE有显著性影响，其OR值分别为1.252和2.835。结论 冠心病血运重建患者的年龄和代谢综合征与发生MACCE密切相关，其可以预测冠心病患者的不良预后。
Abstract:
Objective To investigate the influencing factors of adverse cardiovascular and cerebrovascular events in patients with coronary heart disease revascularization.Methods A retrospective analysis of the clinical data of 613 patients with coronary heart disease who received revascularization treatment in the First Affiliated Hospital of Xinjiang Medical University from July 2012 to July 2014.After a 5-year follow-up, the two groups were divided into two groups based on whether MACCE occurred after the operation. The clinical factors of the two groups were compared, and multivariate Logistic regression was used to analyze the independent predictors of MACCE after revascularization treatment in patients with coronary heart disease.Results During the 5-year follow-up period of 613 patients with coronary heart disease, 135 cases (22.02%) had MACCE, and 478 cases (77.98%) did not have MACCE.Univariate analysis showed that there were statistically significant differences between the two groups in age, fasting blood glucose, impaired glucose tolerance, and metabolic syndrome (P<0.05);Multivariate Logistic regression analysis showed that age and metabolic syndrome had a significant impact on the occurrence of MACCE after revascularization in patients with coronary heart disease, and the OR values were 1.252 and 2.835, respectively.Conclusion The age and metabolic syndrome of patients with coronary heart disease revascularization are closely related to the occurrence of MACCE, which can predict the poor prognosis of patients with coronary heart disease.

参考文献/References:

[1]Ford ES,Giles WH,Dietz WH.Prevalence of the metabolic syndrome among US adults．Findings from the Third National Healthand Nutrition Examination Survey[J].JAMA,2015,287(12):356-359. [2]Mirtschink P,Jang C,Arany Z,et al.Fructose metabolism, cardiometabolic risk,and the epidemic of coronary artery disease[J].Eur Heart J,2018,39(26):2497-2505. [3]郭继东,王喜萍,司军强.踝臂脉搏波速度及糖化血红蛋白与冠心病危险因素的关系[J].山东医药,2013(33):22-24. [4]何晓全,张婧薇,范琰,等.老年冠心病患者冠脉残余病变对PCI术后发生再次血运重建的影响[J].心脏杂志,2018,30(1):53-57,73. [5]武金娥,霍建华,蒋永荣,等.老年冠心病患者PCI术后不良心脑血管事件的随访研究[J].西安交通大学学报(医学版),2019,40(4):579-582. [6]余云华,于亚梅,李茂巍,等.高龄冠心病患者PCI术后主要心脑血管不良事件风险评估模型验证与分析研究[J].介入放射学杂志,2018,27(10):49-54. [7]苏铭.老年冠心病患者PCI术后发生不良心脑血管事件的评估及临床分析[J].现代医用影像学,2019,28(1):184-186. [8]Delgado-Lista J,Perez-Martinez P,Garcia-Rios A,et al.CORonary Diet Intervention with Olive oil and cardiovascular PREVention study(the CORDIOPREV study):Rationale,methods,and baseline characteristics:A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients[J].Am Heart J,2016,177(1):42-50. [9]李茂巍,张必利,郑兴,等.高龄冠心病患者PCI术后院内不良心血管事件发生的危险因素评分[J].第二军医大学学报,2015,36(8):851-857. [10]李景隆,罗灿伟,黄连娇,等.高龄冠心病患者多支血管病变PCI术后发生MACE的危险因素研究[J].海南医学,2020,31(21):2733-2735. [11]卞申国.冠心病PCI术后心脏不良事件及其危险因素临床研究[J].河南医学高等专科学校学报,2020,32(3):279-281. [12]杨帆,孙战文.不同血运重建方式治疗复杂冠状动脉病变伴左心功能不全的疗效及安全性[J].中西医结合心脑血管病杂志,2019,17(12):1837-1840. [13]Collet C,Onuma Y,Andreini D,et al.Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease[J].Eur Heart J,2018,39(41):3689-3698. [14]Ferrari C,Olivares P,Cavallotti L,et al.Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease:Insights From the SYNTAX III REVOLUTION Trial[J].Circ Cardiovasc Interv,2019,12(12):e007607. [15]Volkers EJ,Algra A,Kappelle LJ,et al.Safety of Carotid Revascularization in Patients With a History of Coronary Heart Disease[J].Stroke,2019,50(2):413-418. [16]Tajstra M,Hrapkowicz T,Hawranek M,et al.Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease:5-Year Clinical Outcomes of the Prospective Randomized Pilot Study[J].JACC Cardiovasc Interv,2018,11(9):847-852.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(16):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(16):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(16):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(16):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(16):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(16):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(16):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(16):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(16):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(16):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]

更新日期/Last Update: 1900-01-01